Biotechnologies S.A.S.U. LFB insider trades: Tg Therapeutics (TGTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Biotechnologies reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 17, 2015 | TGTX | ↑ Buy | 114,855 | $6.53 | $750K | Direct | May 11, 2015 (83d) |
| Nov 2, 2009 | GTCB | ↑ Buy | 3,387,851 | $1.07 | $3.6M | Direct | Nov 4, 2009 (2d) |
| Feb 12, 2008 | GTCB | ↑ Buy | 2,018,404 | $0.87 | $1.8M | Direct | Feb 25, 2008 (13d) |
| Jan 3, 2007 | GTCB | ↑ Buy | 3,630,000 | $1.23 | $4.5M | Direct | Jan 5, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TGTX insiders
Open-market trades in the last 12 months
About Biotechnologies S.A.S.U. LFB's insider trades
Biotechnologies S.A.S.U. LFB is a 10% owner of Tg Therapeutics (TGTX). Since Jan 3, 2007, Biotechnologies has reported 4 open-market purchases worth $10.6M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (3 filings), conversions (3 filings), option exercises (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TGTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.